Browsing by Author Stavropoulos, N. E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 15 of 15
TitleAuthor(s)Issue date
Bilateral papillary renal cell carcinomaGossios, K.; Argyropoulou, M.; Vazakas, P.; Stefanaki, S.; Stavropoulos, N. E.24-Nov-2015
A clinicopathological study of the expression of extracellular matrix components in urothelial carcinomaIoachim, E.; Michael, M.; Stavropoulos, N. E.; Kitsiou, E.; Salmas, M.; Malamou-Mitsi, V.24-Nov-2015
Endometrioid carcinoma of the prostate. The diagnostic value of Leu7 and prostatic specific antigenStavropoulos, N. E.; Ioackim-Velogianni, E.; Sidoni, K.; Stefanou, D.; Klouvas, G.; Pavlidis, N.24-Nov-2015
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha expression in bladder cancer and their associations with other angiogenesis-related proteinsIoachim, E.; Michael, M.; Salmas, M.; Michael, M. M.; Stavropoulos, N. E.; Malamou-Mitsi, V.24-Nov-2015
Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinomaIoachim, E.; Charchanti, A.; Stavropoulos, N. E.; Skopelitou, A.; Athanassiou, E.; Agnantis, N. J.24-Nov-2015
Immunohistochemical prognostic markers in bladder cancerIoachim, E.; Stavropoulos, N. E.; Charalabopoulos, K.; Agnantis, N. J.24-Nov-2015
Lipid peroxidation and the use of emulsified propofol in laparoscopic surgeryManataki, A. D.; Tselepis, A. D.; Glantzounis, G. K.; Arnaoutoglou, H. M.; Tsimoyiannis, E. C.; Stavropoulos, N. E.24-Nov-2015
The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II urinary bladder tumor cellsSkalkos, D.; Stavropoulos, N. E.; Tsimaris, I.; Gioti, E.; Stalikas, C. D.; Nseyo, U. O.; Ioachim, E.; Agnantis, N. J.24-Nov-2015
Local immune response after intravesical interferon gamma in superficial bladder cancerStavropoulos, N. E.; Ioachim, E.; Pavlidis, N.; Pappa, L.; Kalomiris, P.; Agnantis, N. J.24-Nov-2015
Localization of metallothionein in urothelial carcinoma of the human urinary bladder: an immunohistochemical study including correlation with HLA-DR antigen, p53, and proliferation indicesIoachim, E. E.; Charchanti, A. V.; Stavropoulos, N. E.; Athanassiou, E.; Michael, M. C.; Agnantis, N. J.24-Nov-2015
Lymphocyte subsets in superficial bladder cancer: correlation with biological activity of the tumoursStavropoulos, N. E.; Ioachim, E.; Hastazeris, K.; Goussia, A.; Agnantis, N. J.24-Nov-2015
Prognostic significance of thymidine phosphorylase in superficial bladder carcinomaStavropoulos, N. E.; Bouropoulos, C.; Ioachim, E.; Michael, M.; Hastazeris, K.; Tsimaris, I.; Kalogeras, D.; Liamis, Z.; Kafarakis, V.; Stefanaki, S.; Malamou-Mitsi, V.24-Nov-2015
Radical therapy for muscle-infiltrating bladder cancer (cystectomy or radiotherapy): does age affect the final therapeutic benefit for the patient?Kalogeras, D.; Lampri, E.; Goussia, A.; Bai, M.; Capizzello, A.; Tassiou, I.; Stavropoulos, N. E.; Tsekeris, P.24-Nov-2015
Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix componentsIoachim, E.; Michael, M. C.; Salmas, M.; Damala, K.; Tsanou, E.; Michael, M. M.; Malamou-Mitsi, V.; Stavropoulos, N. E.24-Nov-2015
Tumor markers in stage P1 bladder cancerStavropoulos, N. E.; Ioachim, E.; Charchanti, A.; Michael, M. C.; Kitsiou, E.; Mihailidis, I.; Hastazeris, K.; Agnantis, N. J.24-Nov-2015